State of Wyoming’s Indivior Pharmaceuticals INDV Stock Holding History

State of Wyoming’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$152K	Sell	3,706 -1,916	-34%	-$69.5K	0.02%	1183
2026 Q1	$171K	Sell	5,622 -15,015	-73%	-$496K	0.02%	1046
2025 Q4	$740K	Sell	20,637 -1,902	-8%	-$58.1K	0.08%	182
2025 Q3	$543K	Buy	22,539 +15,057	+201%	+$315K	0.06%	274
2025 Q2	$110K	Sell	7,482 -20,136	-73%	-$235K	0.01%	1259
2025 Q1	$263K	Sell	27,618 -12,120	-30%	-$127K	0.03%	635
2024 Q4	$494K	Sell	39,738 -36,106	-48%	-$371K	0.06%	271
2024 Q3	$739K	Buy	75,844 +13,354	+21%	+$156K	0.11%	106
2024 Q2	$1.01M	Buy	62,490 +17,072	+38%	+$308K	0.17%	40
2024 Q1	$973K	Buy	45,418 +38,118	+522%	+$716K	0.16%	49
2023 Q4	$112K	Buy	7,300 +4,225	+137%	+$75K	0.02%	909
2023 Q3	$67.6K	Buy	+3,075	New	+$70.1K	0.01%	1111

Other funds holding INDV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CAM

Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

State of Wyoming's INDV Position: Q2 2026 in Review

State of Wyoming reduced its Indivior Pharmaceuticals (INDV) stake by 34% in Q2 2026, selling an estimated $69.5K and leaving 3,706 shares worth $152K. The position accounts for 0.02% of the portfolio, ranked #1183.

State of Wyoming first reported a position in INDV in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.01M in Q2 2024. 125 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

State of Wyoming held 3,706 shares of Indivior Pharmaceuticals worth $152K as of Q2 2026.
State of Wyoming sold 1,916 Indivior Pharmaceuticals shares in Q2 2026, an estimated $69.5K.
Indivior Pharmaceuticals made up 0.02% of State of Wyoming's portfolio in Q2 2026, its #1183 holding.
State of Wyoming first reported a position in Indivior Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
State of Wyoming's Indivior Pharmaceuticals position peaked at $1.01M in Q2 2024.
125 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.